James Risbon

James P. Risbon serves as a Contracting Officer for the 246-NETWORK Contracting Office 6 (36C246) within the Department of Veterans Affairs, where he is responsible for executing complex procurements that sustain and modernize the clinical and operational infrastructure of Veterans Health Administration facilities. His portfolio centers on the acquisition of medical equipment, diagnostic systems, and specialized support services critical to surgical and electromedical care delivery. As the primary contracting authority, he ensures compliance with federal acquisition regulations while aligning procurement decisions with the agency’s mission to enhance veteran healthcare outcomes through technological advancement and facility readiness. Risbon maintains enduring relationships with leading medical technology and life sciences vendors, including Cepheid, Roche Diagnostics Corporation, Progenics Pharmaceuticals, and Southeastern Industrial Barlovento JV-2, LLC. These partnerships reflect a focus on high-precision diagnostic manufacturing, pharmaceutical preparation, and specialized logistics services essential to VA clinical operations. His contracting approach emphasizes performance-based outcomes, technical specificity, and long-term vendor accountability, fostering reliable supply chains for mission-critical healthcare solutions. His set-aside preferences are overwhelmingly oriented toward open competition, with 85.1% of awards issued without socioeconomic set-asides. However, he consistently supports small business participation through targeted Service-Disabled Veteran-Owned Small Business (SDVOSB) set-asides (8.1%) and Total Small Business Set-Asides (6.8%), demonstrating a balanced commitment to both efficiency and socioeconomic goals under FAR Part 19. Risbon’s procurement expertise is concentrated in NAICS categories including 325413 (In-Vitro Diagnostic Substance Manufacturing), 339112 (Surgical and Medical Instrument Manufacturing), and 334517 (Irradiation Apparatus Manufacturing). He regularly acquires advanced diagnostic platforms, surgical instrumentation, and radiation-based medical devices, reflecting deep technical fluency in clinical diagnostics, biomedical engineering, and healthcare infrastructure modernization. His work directly supports the VA’s imperative to deliver cutting-edge, safe, and effective care to veterans.